Search
for
Sort by
Research 121–150 of 1000+
- The JAK/STAT signaling pathway: from bench to clinic
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Baricitinib: A Review in Severe Alopecia Areata
- Annual Convention in the Time of COVID
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- P100: Efficacy of current treatments under study in patients with alopecia areata
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Update: baricitinib for alopecia areata
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- The Role of Janus Kinase Inhibitors in Dermatology
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms